<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3143377/" ref="ordinalpos=646&amp;ncbi_uid=3636675&amp;link_uid=PMC3143377" image-link="/pmc/articles/PMC3143377/figure/F3/" class="imagepopup">Figure 3. Targeting the B-cell receptor <span class="highlight" style="background-color:">signaling</span> <span class="highlight" style="background-color:">pathway</span>..  From: Molecular Targeted Approaches in Mantle Cell lymphoma.. </a></div><br /><div class="p4l_captionBody">The B-cell receptor signaling pathway is initiated through phosphorylation of co-receptors Igα (CD79a) and Igβ (CD79b), recruiting the tyrosine kinase SYK. In turn, SYK phosphorylates several downstream kinases including BTK and PI3Kδ. Activation of PI3Kδ and phospholipase C (PLC) generates PIP3 and diacylglycerol (DAG), respectively. DAG is necessary for activation of protein kinase C (PKC). Inhibitors targeting the signaling cascade downstream of the BCR in clinical development are indicated.</div></div>